COMMUNICATION
Protein Kinase B/Akt Induces Resumption of Meiosis in
Xenopus Oocytes*
Carsten B.
Andersen
§,
Richard A.
Roth¶, and
Marco
Conti
From the
Department of Gynecology and Obstetrics,
Division of Reproductive Biology, and ¶ Department of Molecular
Pharmacology, Stanford University School of Medicine,
Stanford, California 94305-5317
 |
ABSTRACT |
The activation of protein kinase B/Akt is thought
to be a critical step in the phosphoinositide 3-kinase pathway that
regulates cell growth and differentiation. Because insulin-like growth
factor 1 stimulates the resumption of meiosis in Xenopus
laevis oocytes via phosphoinositide 3-kinase activation, we
investigated the Akt involvement in this process. Injection of mRNA
coding for a constitutively active Akt in Xenopus oocytes
induced germinal vesicle breakdown (GVBD) to the same extent as
progesterone or insulin treatment. Injection of mRNA coding for the
wild type Akt kinase was less effective in stimulating GVBD, whereas
Akt bearing a lysine mutation in the catalytic domain that abolishes the kinase activity had no effect. A mutant Akt lacking a
membrane-targeting sequence did not induce GVBD, despite high levels of
expression and activity. As previously reported for insulin, induction
of GVBD by Akt was prevented by incubating the oocytes with
cilostamide, an inhibitor specific for the type 3 phosphodiesterase
(PDE3), suggesting that the activity of a PDE is required for Akt
action. That an increase in PDE activity in the oocyte is sufficient to induce meiotic resumption was demonstrated by expression of an active
PDE protein. In addition, the constitutively active Akt caused a 2-fold
increase in the activity of the endogenous PDE. These data demonstrate
that Akt is in the pathway controlling resumption of meiosis in the
Xenopus oocyte and that regulation of the activity of a
PDE3 is a step distal to the kinase activation.
 |
INTRODUCTION |
A critical step in growth factor stimulation of the target cell is
the activation of the phosphoinositide 3-kinase
(PI3-K)1 pathway. This
signaling pathway has been implicated in a wide array of cellular
events including mitogenesis, transformation, differentiation, and
regulation of metabolism (1). Recently Akt, also known as protein
kinase B or related to the A and protein kinase C (2-4), was
identified as a kinase distal to PI3-K (1). Three Akt isoforms (
,
, and
) with closely related properties have been identified.
These are proteins of approximately 60 kDa containing a pleckstrin
homology (PH) domain (5) and a serine/threonine kinase domain
structurally related to the catalytic domains of protein kinases A and
C. Phosphatidylinositol 3,4-bisphosphate and 3,4,5-trisphosphate, the
products of PI3-K, bind to the PH domain of Akt and serve to anchor the
enzyme to the membrane as well as to induce a conformational change in
the enzyme (6). The subsequent phosphorylation of Akt, at Thr-308 in
the catalytic domain and Ser-473 of the C terminus of Akt
, is
crucial for the activation of Akt (7, 8). At least one of the kinases
phosphorylating Akt has been identified as the
3-phosphoinositide-dependent kinase-1 (9-11).
Akt is activated by insulin and IGF-1 (12), and this regulation
mediates the activation of glucose uptake (13), the phosphorylation and
deactivation of GSK3 (14), and activation of p70 S6 kinases (15). Akt
also phosphorylates the proapoptotic protein Bad, promoting its
interaction with 14-3-3 and thereby preventing apoptosis (16).
In somatic cells including adipocytes, insulin regulates the activation
of cGMP-inhibited phosphodiesterase (PDE3) (17). This activation is
mediated by PI3-K because wortmannin, a PI3-K inhibitor, blocks the
insulin-dependent activation of the PDE (18). The PDE3B
isoform expressed in adipocytes is phosphorylated following insulin
stimulation, and the phosphorylation is associated with an increase in
PDE activity (19). This PDE activation and the consequent decrease in
intracellular cAMP are probably responsible for the decrease in the
hormone-sensitive lipase activity (17) and for the antilipolytic
effects of insulin. The properties of the kinase phosphorylating PDE3B
have not been firmly established, although a recent report indicates
that Akt coelutes with a kinase activity that phosphorylates PDE3B in a
cell-free system (20).
In Xenopus laevis oocytes, IGF-1 induces the dissolution of
the nuclear membrane (GVBD) and completion of the first meiotic division (21). Although distinct signaling pathways may be activated, IGF-1, or the physiological stimulus progesterone, activates meiotic resumption by inducing a transient decrease in intraoocyte cAMP levels,
thereby reducing the protein kinase A activity (22, 23). It has been
proposed that activation of a PDE and a decrease in cAMP are crucial
steps for reentry into the cell cycle. The effects of insulin and IGF-1
on meiosis are blocked by cilostamide, a specific inhibitor of the type
3 family of phosphodiesterases (24). Furthermore, insulin treatment or
injection of an activated Ras leads to an increase in the PDE activity
in the Xenopus oocyte (25).
Here we have tested the hypothesis that Akt is involved in the
IGF-1-induced resumption of meiosis by activating a PDE present in the
Xenopus oocyte. Our data demonstrate that Akt is a signal for resumption of meiosis in the Xenopus oocyte and that
activation of a PDE3 is a step distal to the Akt activation.
 |
MATERIALS AND METHODS |
Construction of mRNA Expression Vectors--
The constructs
encoding the wild type (WT)-Akt
, myristoylated (myr)-Akt, K179M-Akt,
and A2myr-Akt have been described (12, 13). These constructs were
transferred from the pECE vector to the XbaI-SalI
sites of the mRNA expression vector pSP64(poly(A)) (Promega,
Madison WI). The pCMV-5 iSH2-p110 (a gift from M. Birnbaum) was
subcloned into pSP64(poly(A)) using XbaI and
BamHI for the p110 subunit and XbaI for the
inter-SH-2 domain (iSH2-I) of p85. The pCMV-5 rat PDE4D3 construct has
been described previously (26). The complete open reading frame of
PDE4D3 was subcloned from pCMV-5 into EcoRI of pBluescript
KSII and then into pSP64(poly(A)) using
AvaI-HindIII. All Akt constructs had the
influenza virus HA epitope tag fused in-frame to the C terminus to
monitor protein expression.
In Vitro mRNA Synthesis--
To express Akt, PI3-K, and
PDE4D3 mRNAs, the pSP64(poly(A)) constructs were transcribed using
the SP6 polymerase according to the procedure supplied by the
manufacturer (Message Machine Kit, Promega). The transcribed mRNA
was purified by phenol/chloroform extraction, precipitated at
20 °C with 1 volume of isopropyl alcohol, and resuspended in
diethylpyrocarbonate water. The mRNA concentration was measured by
A260, and transcript size was determined by
formaldehyde gel electrophoresis. The mRNA was diluted to 1 mg/ml
in diethylpyrocarbonate water and stored at
70 °C.
Injection into Xenopus Oocytes--
Ovary fragments were
surgically removed from pregnant mare serum gonadotropin-primed
X. laevis, and the oocytes were isolated manually. Stage VI
oocytes were selected for all the experiments. Oocyte storage and
experiments were carried out in OR2 solution (82.5 mM NaCl,
2.5 mM KCl, 1.0 mM CaCl2, 1.0 mM MgCl2, 1.0 mM Na2HPO4, 5.0 mM HEPES, pH 7.8).
Oocytes were routinely tested for their insulin responsiveness by
incubation of 10 oocytes in 1 µM insulin in OR2 solution
overnight at room temperature. Oocytes that exhibited an
insulin-stimulated GVBD of 80-100% were used. The mRNA or
H2O (vehicle) was injected using a micromanipulator (Drummond) into defolliculated Xenopus oocytes. Resumption
of meiosis was scored by the appearance of a white spot on the animal pole of the oocyte.
Western Blot Analysis--
Expression of HA-tagged Akt was
analyzed after lysing injected oocytes in 10 µl of lysis buffer (250 mM sucrose, 1 mM KCl, 1 mM MgCl,
0.2 mM phenylmethylsulfonyl fluoride) per oocyte. Oocyte extracts were isolated by centrifugation at 15,000 × g
for 10 min at 4 °C. The lipid supernatant was removed, and the
clarified supernatants were transferred to Eppendorf tubes. Oocyte
extract were analyzed by gel electrophoresis on 8% SDS-polyacrylamide gel electrophoresis (1:30 bis:acrylamide). After transfer,
nitrocellulose membranes were blocked overnight at 4 °C in 5%
bovine serum albumin in Tris-buffered saline with 0.02% Tween 20. Immunostaining to detect Akt-HA expression was performed by incubating
for 1 h with a 1:1000 dilution of an HA.11 polyclonal antibody
(Babco) and subsequently with a 1:5000 dilution of anti-rabbit Ig
conjugated to horseradish peroxidase (Amersham Pharmacia Biotech).
Blots were visualized by the ECL procedure (Amersham Pharmacia
Biotech). Western blot for endogenous ERK2 phosphorylation was
performed as described previously (27).
In Vivo PDE Assay--
PDE activity was measured in
Xenopus oocytes by the method described by Sadler and Maller
(23). In brief, oocytes were first stimulated with insulin or injected
with either PI3-K, K179M-Akt, or myr-Akt mRNA. Three hours later,
they were reinjected with 50 nl of 2 mM
[3H]cAMP to a final concentration of 200 µM
(500-700 cpm/pmol). The reaction products were separated and
quantitated as previously described (23, 28).
Akt Assay--
Oocytes were lysed as described above, and the
expressed Akt was immunoprecipitated and analyzed for activity as
described (12). GSK peptide GRPRTSSFAEG was used as substrate (14). Akt
activity was determined by both densitometry and scintillation counting.
 |
RESULTS |
Akt Stimulation of Meiotic Resumption in Xenopus Oocytes--
To
test whether Akt is involved in the resumption of meiosis, an mRNA
encoding a constitutively active Akt (7) was microinjected in
Xenopus oocytes; in this construct, the Akt coding region
with a deletion in the PH domain (
4-129) is fused to a 14-amino
acid leader containing the myr sequence of src (myr-Akt).
This engineered protein is constitutively active in 3T3L1 cells by
being targeted to the membrane (7). The expression of this
constitutively active Akt caused resumption of meiosis as measured by
GVBD (Fig. 1). The effect of active Akt
expression was comparable with the insulin or progesterone stimulation
(Fig. 1). When the time course of GVBD was monitored after myr-Akt
injection, half-maximal maturation occurred 9.3 ± 1.6 h
after injection (data not shown), whereas progesterone- and
insulin-induced GVBD occurred with half-times of 2.9 ± 0.3 and
4.8 ± 0.7 h, respectively.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 1.
Microinjection of mRNA coding for a
constitutively active Akt (myr-Akt) stimulates meiotic resumption in
Xenopus oocytes. Stage VI oocytes were treated with
either 1 µM insulin or 10 µM progesterone
(not injected groups) or injected with 50 nl of H2O or 50 ng (1 mg/ml) of myr-Akt (injected groups). The number in parentheses
denotes the number of oocytes injected for each group. Oocytes were
incubated at 20 °C after treatment, and GVBD was scored after
20 h. Maturation is expressed as the percentage of oocytes
exhibiting GVBD ± S.E. of five independent experiments.
|
|
Additional constructs were used to determine whether the kinase
activity and the membrane targeting are necessary for the Akt-induced
resumption of meiosis. The glycine in position 2 of the myristoylation
sequence of myr-Akt was mutated to alanine (A2myr-Akt). This possesses
basal activity but is not constitutively activated, presumably because
its interaction with the membrane is disrupted. A kinase-deficient
mutant was obtained by a lysine to methionine mutation (K179M) in the
ATP binding motif (K179M-Akt). Constructs encoding a full-length Akt
clone (WT-Akt) and a constitutive active PI3-K were used as controls.
Oocytes injected with myr-Akt produced 100% GVBD, whereas the WT-Akt
was less effective (Fig. 2A).
The myristoylation-deficient A2myr-Akt and kinase-deficient K179M-Akt
were both inactive in promoting meiotic resumption (Fig. 2A). Western blot analyses using an anti-HA polyclonal
antibody demonstrated that the A2myr-Akt and the K179M-Akt proteins
accumulated at high levels in the oocyte (Fig. 2B). This
finding rules out the possibility that the constructs with the point
mutations are inactive because of instability and impaired accumulation
of these mutant proteins. The assay of the Akt kinase activity
confirmed that constitutively active myr-Akt has an 8-10-fold higher
activity than WT-Akt, whereas the K179M-Akt has no measurable activity (Fig. 2C). Although completely inactive in the induction of
meiosis, the A2myr-Akt had considerable kinase activity (Fig.
2C). These data indicate that Akt has to be both localized
and active to stimulate resumption of meiosis. Western blot analyses of
Xenopus extracts with mitogen-activated protein kinase
antibodies verified that injection of the constitutively active Akt,
but not the kinase-dead mutant, induces phosphorylation of ERK2
together with the induction of GVBD (data not shown).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 2.
Stimulation of meiotic resumption by
different Akt constructs. A, stage VI oocytes were
subjected to the following injections or treatments: stimulated with 10 µM progesterone or 1 µM insulin
(Not injected group); or injected with 50 nl of
H2O or 50 ng of mRNA per oocyte encoding PI3-K,
myr-Akt, A2myr-Akt, WT-Akt, or K179M-Akt (Injected group).
Maturation is expressed as the percentage of oocytes exhibiting GVBD,
and the values are the means ± S.E. of three independent
experiments with a total of 60 or more oocytes per group. B,
Western blot of the expressed HA-Akt. Immunostaining was performed
using anti-HA.11. C, Akt activity of the expressed Akt. Akt
activity was analyzed as described under "Materials and Methods."
Results shown are representative of the two experiments
performed.
|
|
Activation of a PDE3 Is Distal to Akt in the Maturation
Pathway--
Previous work by Sadler (24) had shown that the
maturation induced by insulin and IGF-1 is blocked by type 3 PDE
inhibitors. To investigate whether a PDE is distal to Akt, different
concentrations (0.2, 0.5, and 1.0 mg/ml) of constitutively active Akt
(myr-Akt) mRNA were injected into Xenopus oocytes
preincubated with inhibitors of PDE3. A 1-h preincubation with 10 µM cilostamide effectively prevented the myr-Akt-induced
meiotic resumption (Fig. 3). Under the
same conditions, 10 µM cilostamide also blocked
insulin-induced maturation (data not shown). Whereas preincubation of
oocytes in 10 µM cilostamide reduced the effect of
microinjected myr-Akt no inhibition was observed by preincubating
oocytes with a type 4 PDE inhibitor, rolipram (data not shown). This
suggests that Akt-stimulated resumption of meiosis requires the
activity of a PDE3, as does IGF-1-stimulated oocyte maturation
(24).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of PDE3 inhibitors on the
Akt-stimulated resumption of meiosis. Oocytes were injected with
50 nl of either 0.2, 0.5, or 1.0 mg/ml myr-Akt mRNA with or without
preincubation for 1 h in 10 µM cilostamide
(Cil), as indicated. Resumption of meiosis (GVBD) was scored
at 15 h after injection, and the results are reported as the
percentage of oocytes exhibiting GVBD. The mean ± S.E. of three
independent experiments is reported.
|
|
To determine whether PDE activation per se is sufficient to
induce resumption of meiosis, a PDE mRNA was injected into the oocytes. The mRNA coding for a PDE4 (PDE4D3) rather than PDE3 was
used for these experiments to distinguish the expressed PDE from the
endogenous PDE activity. Injection of the PDE4D3 mRNA induced GVBD
to the same extent as progesterone or insulin treatment (Fig.
4). This effect was blocked by inhibitors
specific for type 4 PDE (10 µM rolipram) but not by
inhibitors specific for type 3 PDE (cilostamide) (Fig. 4). This finding
demonstrates that the activity of the expressed PDE4 is required for
induction of meiosis. It is also important to note that cilostamide
could not block the meiotic resumption induced by the PDE4D3 injection,
thus ruling out the possibility that the effect of this inhibitor on
the Akt-stimulated maturation is because of effects other than PDE3
inhibition.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of PDE mRNA microinjection on
meiotic resumption. Oocytes were treated with 10 µM
progesterone with or without a 1-h preincubation in 10 µM
rolipram (Not injected). Alternatively, they were injected
(Injected) with 50 nl of H2O or 50 ng per oocyte
rat PDE4D3 mRNA with or without 1-h preincubation with either 10 µM cilostamide (+cil.) or 10 µM
rolipram (+rol.). Maturation is expressed as the percentage
of oocytes exhibiting GVBD. Results are averages of two independent
experiments on 40 or more oocytes per group.
|
|
To test whether Akt activates the endogenous PDE, we next measured cAMP
hydrolysis. Oocytes were injected with 50 ng of myr-Akt mRNA 3 h prior to injection of [3H]cAMP (23). Oocytes injected
with K179M-Akt were used as a control. In parallel, a group of oocytes
was stimulated with insulin 2 h before [3H]cAMP
injection. Injection of the constitutively active Akt caused a 2-fold
increase in cAMP hydrolysis over the control (Table
I). As previously reported (23), insulin
treatment also stimulated cAMP hydrolysis (data not shown).
View this table:
[in this window]
[in a new window]
|
Table I
Akt stimulation of oocyte PDE activity in vivo
Stage VI oocytes were injected with 50 ng of mRNA encoding either
constitutively active PI3-K, constitutively active (myr) Akt, or
kinase-deficient (K179M) Akt. After 3 h the oocytes were
reinjected with 50 nl of 2 mM [3H]cAMP. The cAMP
hydrolysis was measured in three groups of five oocytes per sample as
described under "Materials and Methods." Values are averages ± S.D.
|
|
 |
DISCUSSION |
Akt is a serine-threonine kinase in the PI3-K signaling pathway
that mediates growth factor regulation of cell differentiation and
survival (1). Here we provide evidence for an additional role of this
Akt kinase in the control of the cell cycle and meiosis. Akt expression
in the Xenopus oocyte causes germinal vesicle breakdown and
mitogen-activated protein kinase phosphorylation, hallmarks of the
resumption of meiosis. Furthermore, our findings indicate that a
PDE3 is distal to Akt activation. This conclusion is
supported by both the pharmacological manipulation of the oocyte PDE
and by the observation that an increase in PDE activity follows
expression of the Akt kinase in oocyte. Finally, the finding that
expression of a PDE in the oocyte per se is sufficient to
promote a meiotic resumption is consistent with the above
conclusions.
Numerous observations have underscored the importance of the lipid
PI3-K in insulin and growth factor signaling in somatic cells (1) as
well as in Xenopus oocytes. Because insulin and IGF-1
effects on meiosis are inhibited by wortmannin (29), PI3-K has been
implicated in oocyte maturation. Injection of a constitutively active
PI3-K mRNA causes resumption of meiosis (30), whereas injection of
the lipid phosphatase SIP/SHIP blocks the insulin effects (31). Our
data extend these observations by identifying downstream steps in the
pathway by which IGF-1 induces resumption of meiosis. As for somatic
cells where the PI3-K effects are mediated by activation of Akt, we
have shown that Akt activates resumption of meiosis in a manner similar
to insulin/IGF-1.
Although the myr-Akt efficiently promoted oocyte maturation, a wild
type Akt was only partially effective in the oocyte model, consistent
with observations in mammalian cells showing that wild type Akt has low
basal activity in the absence of insulin or growth factor signals (7,
8, 12, 13). Unlike the myr-Akt, the A2myr-Akt lacking the PH domain and
with a mutation in the myristoylation signal was ineffective in
inducing resumption of meiosis. This protein was efficiently expressed,
and the overall Akt activity recovered in oocyte extracts was
comparable with that obtained by expression of myr-Akt. When the
activity of A2myr-Akt was corrected for the amount of protein
expressed, this mutant kinase had one-fourth the specific activity of
the myr-Akt. Because the only difference between A2myr-Akt and myr-Akt
is the ability to interact with the lipid bilayer, we can conclude that
Akt interaction with lipids is essential for the signaling meiotic
resumption.
Our findings that PDE3 inhibitors block the oocyte maturation induced
by insulin and Akt, but not progesterone, indicate that a PDE3 is
involved in the PI3-K signal transduction pathway activated by
IGF-1/insulin. In agreement with this hypothesis, we have shown that
insulin, PI3-K, and Akt stimulate the activity of PDE3 endogenous to
the oocyte. That Akt activation of PDE3 may be a sufficient signal for
meiosis resumption is strongly suggested by the observation that
expression of a PDE causes GVBD. Our conclusion is consistent with the
finding in adipocytes, where it has been shown that insulin through the
PI3-K pathway activates PDE3B (32).
Our data do not exclude the possibility that Akt is at a branch point
in the signaling pathway controlling maturation. Upon activation, this
kinase may phosphorylate several substrates in addition to a PDE3, and
the activation of a PDE3 has only a permissive role on meiotic
maturation. According to this model, both the release of a
cAMP-dependent blockade and the activation of a distinct signaling cascade may be required for meiotic resumption. For instance,
Akt activates the p70 ribosomal S6 kinase, which may be involved in the
regulation of mos translation, a crucial step in oocyte
meiosis (33).
Regardless of the mechanism of Akt action, our findings indicate a role
for this enzyme in oocyte maturation. Interestingly, the cloning of
3-phosphoinositide-dependent kinase-1, the
kinase-phosphorylating Thr-308 of Akt
, has uncovered a structural
and function homology with the Drosophila DSTPK61 kinase.
Although little is known about the function of the PI3-K and Akt
pathway in Drosophila, DSTPK61 kinase may play an important
role in the differentiation of the female and male germ cells (9). Our
data in the Xenopus oocyte are in line with the view that
this pathway is involved in oocyte maturation. The physiological
signals activating the PI3-K and the Akt pathway are unknown at present
but may be a means by which somatic cells control the function of germ
cells. It is worth noting that the PDE3A mRNA (34) and protein are
expressed in mammalian oocytes. Consistent with that shown in
Xenopus, PDE3 inhibitors block the spontaneous resumption of
meiosis in rat and mouse oocytes as well as the maturation induced by
the luteinizing hormone in the intact follicle (34, 35). Recent
in vivo observations have further confirmed the crucial role
of PDE3 for resumption of meiosis in mammals (35). Thus, our data on
the Xenopus oocyte open the possibility that, in the
mammalian follicle, physiological signals promoting resumption of
meiosis regulate the intraoocyte cAMP levels via the PI3-K/Akt
signaling pathway.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Jim Ferrell for the polyclonal
anti-ERK2 antibody and the helpful discussion; Eric Machleder and Mike
Wu for help with microinjections; Morris Birnbaum for iSH2-p110 clone; and Kristina Kovacina and Aimee Kohn for pECE-Akt constructs.
 |
FOOTNOTES |
*
This work was supported in part by National Institutes of
Health Grants HD20788 and P50 HD31398 Project IV (to M. C.) and DK34976 (to R. A. R.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by Grant UDL9526 from The Danish Research Academy and
Grant 9600503 from The Danish Research Councils.
To whom correspondence should be addressed. Tel.:
650-725-2452; Fax: 650-725-7102; E-mail:
marco.conti{at}forsythe.stanford.edu.
1
The abbreviations used are: PI3-K,
phosphatidylinositol 3-kinase; PDE, phosphodiesterase; IGF-1,
insulin-like growth factor 1; HA, hemagglutinin; myr, myristoylation;
PH, pleckstrin homology; GVBD, germinal vesicle breakdown; WT, wild
type.
 |
REFERENCES |
-
Toker, A.,
and Cantley, L. C.
(1997)
Nature
387,
673-676[CrossRef][Medline]
[Order article via Infotrieve]
-
Coffer, P. J.,
and Woodgett, J. R.
(1991)
Eur. J. Biochem.
201,
475-481[Abstract]
-
Jones, P. F.,
Jakubowicz, T.,
Pitossi, F. J.,
Maurer, F.,
and Hemmings, B. A.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
4171-4175[Abstract]
-
Bellacosa, A.,
Testa, J. R.,
Staal, S. P.,
and Tsichlis, P. N.
(1991)
Science
254,
274-277[Medline]
[Order article via Infotrieve]
-
Haslam, R. J.,
Koide, H. B.,
and Hemmings, B. A.
(1993)
Nature
363,
309-310[Medline]
[Order article via Infotrieve]
-
Hemmings, B. A.
(1997)
Science
277,
534[Free Full Text]
-
Kohn, A. D.,
Takeuchi, F.,
and Roth, R. A.
(1996)
J. Biol. Chem.
271,
21920-21926[Abstract/Free Full Text]
-
Alessi, D. R.,
Andjelkovic, M.,
Caudwell, B.,
Cron, P.,
Morrice, N.,
Cohen, P.,
and Hemmings, B. A.
(1996)
EMBO J.
15,
6541-6551[Abstract]
-
Alessi, D. R.,
Deak, M.,
Casamayor, A.,
Caudwell, F. B.,
Morrice, N.,
Norman, D. G.,
Gaffney, P.,
Reese, C. B.,
MacDougall, C. N.,
Harbison, D.,
Ashworth, A.,
and Bownes, M.
(1997)
Curr. Biol.
7,
776-789[Medline]
[Order article via Infotrieve]
-
Alessi, D. R.,
James, S. R.,
Downes, C. P.,
Holmes, A. B.,
Gaffney, P. R.,
Reese, C. B.,
and Cohen, P.
(1997)
Curr. Biol.
7,
261-269[Medline]
[Order article via Infotrieve]
-
Stokoe, D.,
Stephens, L. R.,
Copeland, T.,
Gaffney, P. R.,
Reese, C. B.,
Painter, G. F.,
Holmes, A. B.,
McCormick, F.,
and Hawkins, P. T.
(1997)
Science
277,
567-570[Abstract/Free Full Text]
-
Kohn, A. D.,
Kovacina, K. S.,
and Roth, R. A.
(1995)
EMBO J.
14,
4288-4295[Abstract]
-
Kohn, A. D.,
Summers, S. A.,
Birnbaum, M. J.,
and Roth, R. A.
(1996)
J. Biol. Chem.
271,
31372-31378[Abstract/Free Full Text]
-
Cross, D. A.,
Alessi, D. R.,
Cohen, P.,
Andjelkovich, M.,
and Hemmings, B. A.
(1995)
Nature
378,
785-789[CrossRef][Medline]
[Order article via Infotrieve]
-
Burgering, B. M.,
and Coffer, P. J.
(1995)
Nature
376,
599-602[CrossRef][Medline]
[Order article via Infotrieve]
-
Datta, S. R.,
Dudek, H.,
Tao, X.,
Masters, S.,
Fu, H.,
Gotoh, Y.,
and Greenberg, M. E.
(1997)
Cell
91,
231-241[Medline]
[Order article via Infotrieve]
-
Degerman, E.,
Smith, C. J.,
Tornqvist, H.,
Vasta, V.,
Belfrage, P.,
and Manganiello, V. C.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
533-537[Abstract]
-
Rahn, T.,
Ridderstrale, M.,
Tornqvist, H.,
Manganiello, V.,
Fredrikson, G.,
Belfrage, P.,
and Degerman, E.
(1994)
FEBS Lett.
350,
314-318[CrossRef][Medline]
[Order article via Infotrieve]
-
Rahn, T.,
Ronnstrand, L.,
Leroy, M. J.,
Wernstedt, C.,
Tornqvist, H.,
Manganiello, V. C.,
Belfrage, P.,
and Degerman, E.
(1996)
J. Biol. Chem.
271,
11575-11580[Abstract/Free Full Text]
-
Wijkander, J.,
Landstrom, T. R.,
Manganiello, V.,
Belfrage, P.,
and Degerman, E.
(1998)
Endocrinology
139,
219-227[Abstract/Free Full Text]
-
Maller, J. L.
(1986)
J. Cyclic Nucleotide Protein Phosphor. Res.
11,
543-555[Medline]
[Order article via Infotrieve]
-
Maller, J. L.,
Butcher, F. R.,
and Krebs, E. G.
(1979)
J. Biol. Chem.
254,
579-582[Abstract]
-
Sadler, S. E.,
and Maller, J. L.
(1987)
J. Biol. Chem.
262,
10644-10650[Abstract/Free Full Text]
-
Sadler, S. E.
(1991)
Mol. Endocrinol.
5,
1939-1946[Abstract]
-
Sadler, S. E.,
and Maller, J. L.
(1989)
J. Biol. Chem.
264,
856-861[Abstract/Free Full Text]
-
Sette, C.,
Vicini, E.,
and Conti, M.
(1994)
J. Biol. Chem.
269,
18271-18274[Abstract/Free Full Text]
-
Walter, S. A.,
Guadagno, T. M.,
and Ferrell, J. E., Jr.
(1997)
Mol. Biol. Cell
8,
2157-2169[Abstract/Free Full Text]
-
Thompson, W. J.,
and Appleman, M. M.
(1971)
Biochemistry
10,
311-316[Medline]
[Order article via Infotrieve]
-
Liu, X. J.,
Sorisky, A.,
Zhu, L.,
and Pawson, T.
(1995)
Mol. Cell. Biol.
15,
3563-3570[Abstract]
-
Hu, Q.,
Klippel, A.,
Muslin, A. J.,
Fantl, W. J.,
and Williams, L. T.
(1995)
Science
268,
100-102[Medline]
[Order article via Infotrieve]
-
Deuter-Reinhard, M.,
Apell, G.,
Pot, D.,
Klippel, A.,
Williams, L. T.,
and Kavanaugh, W. M.
(1997)
Mol. Cell. Biol.
17,
2559-2565[Abstract]
-
Degerman, E.,
Belfrage, P.,
and Manganiello, V. C.
(1996)
Biochem. Soc. Trans.
24,
1010-1014[Medline]
[Order article via Infotrieve]
-
Sagata, N.,
Oskarsson, M.,
Copeland, T.,
Brumbaugh, J.,
and Vande Woude, G. F.
(1988)
Nature
335,
519-525[CrossRef][Medline]
[Order article via Infotrieve]
-
Tsafriri, A.,
Chun, S. Y.,
Zhang, R.,
Hsueh, A. J.,
and Conti, M.
(1996)
Dev. Biol.
178,
393-402[CrossRef][Medline]
[Order article via Infotrieve]
-
Wiersma, A.,
Hirsh, B.,
Tsafriri, A.,
Hanssen, R. J. G. M.,
Van de Kant, M.,
Kloosterboer, H. J.,
Conti, M.,
and Hseuh, A. J. W.
(1998)
XIth International Workshop on Development and Function of the Reproductive Organs, p. 15, Amsterdam, Netherlands
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.